Dabrafenib,Trametinib
Novartis
['trametinib', 'basket trial', 'roar,basket', 'roar', 'dabrafenib']
this study published in lead to inclusion in nccn guidelines 4/10 dabrafenib plus trametinib in patients with brafv600e-mutated biliary tract cancer (roar): a phase 2, open-label, single-arm, multicentre basket trial #aacr23 
Oncologist | Associate Prof | Executive Director-Research, MD Anderson Cancer Network | Medical Director, Clinical Center for Targeted Therapy. Tweets = my own.